Overview

Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patients

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether plasma levels of lipopolysaccharide binding protein (LBP) are correlated with PBMN pro- and anti-inflammatory cytokine secretion, as well as with the development of severe infectious events in cirrhotic patients with ascites. As a secondary purpose, the study will evaluate the effect of a prophylactic administration of ciprofloxacin on LBP, cytokines and infections in the same patients.
Phase:
Phase 4
Details
Lead Sponsor:
Florencia Vargas-Vorackova
Collaborator:
Laboratorios Senosiain, S.A. de C.V.
Treatments:
Ciprofloxacin